Innate Pharma Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 02/12/2026 | 92.75 K | $162.32 M | 100.00% | 0.11% |
| MORGAN STANLEY | 02/13/2026 | 46.39 K | $81.19 K | -13.39% | 0.05% |
| OLD MISSION CAPITAL LLC | 02/17/2026 | 28.43 K | $49.75 K | 100.00% | 0.03% |
| RHUMBLINE ADVISERS | 02/13/2026 | 5.20 K | $9.11 K | 1,007.23% | 0.01% |
| GAMMA INVESTING LLC | 01/05/2026 | 1.07 K | $1.88 M | -52.96% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 947 | $1.66 M | -80.26% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 10 | $18.00 K | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 1 | $2.00 K | -99.67% | 0.00% |
| PRINCIPAL SECURITIES, INC. | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Innate Pharma institutional Ownership - FAQ's
During the previous two years, 11 institutional investors and hedge funds held shares of Innate Pharma. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 92,753
MORGAN STANLEY: 46,394
RHUMBLINE ADVISERS: 5,204
GAMMA Investing LLC: 1,073
UBS Group AG: 947
Farther Finance Advisors, LLC: 10
0.17% of Innate Pharma stock is owned by institutional investors.
Institutional investors have bought a total of 146.40 K shares in the last 24 months. This purchase volume represents approximately $248.87 K in transactions.